大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/06/21 | 2,110 | 2,122 | 2,085 | 2,091 | -19 | -0.9% | 10,700 |
2018/06/20 | 2,101 | 2,114 | 2,074 | 2,110 | ±0 | ±0% | 15,000 |
2018/06/19 | 2,155 | 2,155 | 2,101 | 2,110 | -38 | -1.8% | 21,000 |
2018/06/18 | 2,190 | 2,190 | 2,136 | 2,148 | -4 | -0.2% | 12,100 |
2018/06/15 | 2,169 | 2,183 | 2,133 | 2,152 | +2 | +0.1% | 12,400 |
2018/06/14 | 2,137 | 2,169 | 2,107 | 2,150 | ±0 | ±0% | 20,800 |
2018/06/13 | 2,132 | 2,159 | 2,109 | 2,150 | +32 | +1.5% | 14,500 |
2018/06/12 | 2,100 | 2,127 | 2,100 | 2,118 | +31 | +1.5% | 16,400 |
2018/06/11 | 2,111 | 2,142 | 2,074 | 2,087 | -9 | -0.4% | 25,600 |
2018/06/08 | 2,074 | 2,127 | 2,074 | 2,096 | +3 | +0.1% | 28,400 |
2018/06/07 | 2,099 | 2,105 | 2,072 | 2,093 | +7 | +0.3% | 23,500 |
2018/06/06 | 2,066 | 2,091 | 2,066 | 2,086 | +11 | +0.5% | 20,600 |
2018/06/05 | 2,087 | 2,099 | 2,052 | 2,075 | -8 | -0.4% | 25,900 |
2018/06/04 | 2,090 | 2,090 | 2,068 | 2,083 | +1 | ±0% | 17,100 |
2018/06/01 | 2,063 | 2,103 | 2,063 | 2,082 | +19 | +0.9% | 28,400 |
2018/05/31 | 2,052 | 2,079 | 2,050 | 2,063 | +36 | +1.8% | 23,700 |
2018/05/30 | 2,022 | 2,046 | 2,020 | 2,027 | -1 | ±0% | 18,200 |
2018/05/29 | 2,021 | 2,039 | 1,982 | 2,028 | +7 | +0.3% | 33,800 |
2018/05/28 | 2,042 | 2,047 | 2,014 | 2,021 | +2 | +0.1% | 12,900 |
2018/05/25 | 2,037 | 2,037 | 2,006 | 2,019 | -10 | -0.5% | 18,000 |
2018/05/24 | 2,054 | 2,059 | 2,023 | 2,029 | -7 | -0.3% | 14,500 |
2018/05/23 | 2,057 | 2,057 | 2,016 | 2,036 | -21 | -1% | 33,500 |
2018/05/22 | 2,060 | 2,079 | 2,051 | 2,057 | ±0 | ±0% | 16,800 |
2018/05/21 | 2,049 | 2,087 | 2,049 | 2,057 | +29 | +1.4% | 16,500 |
2018/05/18 | 2,036 | 2,058 | 2,025 | 2,028 | -8 | -0.4% | 14,200 |
2018/05/17 | 2,048 | 2,059 | 2,022 | 2,036 | -20 | -1% | 38,700 |
2018/05/16 | 2,061 | 2,068 | 2,050 | 2,056 | -5 | -0.2% | 12,200 |
2018/05/15 | 2,101 | 2,101 | 2,058 | 2,061 | -32 | -1.5% | 18,100 |
2018/05/14 | 2,042 | 2,104 | 2,035 | 2,093 | -45 | -2.1% | 33,600 |
2018/05/11 | 2,110 | 2,150 | 2,089 | 2,138 | +28 | +1.3% | 16,200 |
2018/05/10 | 2,117 | 2,123 | 2,086 | 2,110 | +2 | +0.1% | 15,000 |
2018/05/09 | 2,173 | 2,173 | 2,096 | 2,108 | -63 | -2.9% | 20,100 |
2018/05/08 | 2,195 | 2,195 | 2,150 | 2,171 | -4 | -0.2% | 20,300 |
2018/05/07 | 2,147 | 2,181 | 2,103 | 2,175 | +36 | +1.7% | 20,100 |
2018/05/02 | 2,122 | 2,142 | 2,090 | 2,139 | +18 | +0.8% | 23,500 |
2018/05/01 | 2,150 | 2,150 | 2,067 | 2,121 | +18 | +0.9% | 26,800 |
2018/04/27 | 2,088 | 2,103 | 2,046 | 2,103 | +16 | +0.8% | 18,900 |
2018/04/26 | 2,043 | 2,092 | 2,036 | 2,087 | +45 | +2.2% | 21,900 |
2018/04/25 | 2,047 | 2,049 | 2,035 | 2,042 | -5 | -0.2% | 14,700 |
2018/04/24 | 2,032 | 2,048 | 2,030 | 2,047 | +15 | +0.7% | 10,600 |
2018/04/23 | 2,021 | 2,037 | 2,006 | 2,032 | +17 | +0.8% | 13,300 |
2018/04/20 | 2,012 | 2,044 | 2,007 | 2,015 | +2 | +0.1% | 15,900 |
2018/04/19 | 2,021 | 2,021 | 2,001 | 2,013 | -3 | -0.1% | 13,700 |
2018/04/18 | 1,990 | 2,032 | 1,990 | 2,016 | +20 | +1% | 20,400 |
2018/04/17 | 1,990 | 1,998 | 1,971 | 1,996 | -3 | -0.2% | 11,200 |
2018/04/16 | 1,972 | 1,999 | 1,968 | 1,999 | +23 | +1.2% | 13,600 |
2018/04/13 | 1,967 | 1,985 | 1,956 | 1,976 | +13 | +0.7% | 10,700 |
2018/04/12 | 1,969 | 1,984 | 1,952 | 1,963 | -7 | -0.4% | 15,000 |
2018/04/11 | 2,006 | 2,007 | 1,962 | 1,970 | -30 | -1.5% | 25,700 |
2018/04/10 | 2,000 | 2,021 | 1,980 | 2,000 | -12 | -0.6% | 14,100 |
1751~
1800
件表示中 / 4021件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステムリム | 31,500円 | - | - | 0.00% | - | 2.90倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
オンコリス | 71,200円 | +3771.0% | - | 0.00% | - | 12.41倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
市場注目の銘柄
チャート関連のコラム